Search Page

1

Cite

Share

Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.

Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Hameleers N, Wouters EFM, Janssen DJA. Verberkt CA, et al. JAMA Intern Med. 2020 Oct 1;180(10):1306-1314. doi: 10.1001/jamainternmed.2020.3134. JAMA Intern Med. 2020. PMID: 32804188 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Attitudes of patients with chronic breathlessness towards treatment with opioids.

Verberkt CA, van den Beuken-van Everdingen MHJ, Wouters EFM, Janssen DJA. Verberkt CA, et al. Eur Respir J. 2020 Feb 20;55(2):1901752. doi: 10.1183/13993003.01752-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 31699842 Free article. No abstract available.

Cite

Share

3

Cite

Share

Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.

Verberkt CA, van den Beuken-van Everdingen MHJ, Dirksen CD, Schols JMGA, Wouters EFM, Janssen DJA. Verberkt CA, et al. Respir Med. 2021 Apr;179:106330. doi: 10.1016/j.rmed.2021.106330. Epub 2021 Feb 10. Respir Med. 2021. PMID: 33611087 Clinical Trial.

Cite

Share

4

Cite

Share

Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis.

Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Datla S, Dirksen CD, Johnson MJ, van Kuijk SMJ, Wouters EFM, Janssen DJA. Verberkt CA, et al. Eur Respir J. 2017 Nov 22;50(5):1701153. doi: 10.1183/13993003.01153-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29167300 Free article. Review.

Cite

Share

5

Cite

Share

Healthcare and Societal Costs in Patients with COPD and Breathlessness after Completion of a Comprehensive Rehabilitation Program.

Verberkt CA, van den Beuken-van Everdingen MHJ, Dirksen CD, Schols JMGA, Vanfleteren LEGW, Franssen FME, Groenen MTJ, Wouters EFM, Janssen DJA. Verberkt CA, et al. COPD. 2021 Apr;18(2):170-180. doi: 10.1080/15412555.2020.1868420. Epub 2021 Mar 10. COPD. 2021. PMID: 33719787

Cite

Share

6

Cite

Share

Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness.

Janssen DJA, van den Beuken-van Everdingen MHJ, Verberkt CA, Creemers JPHM, Wouters EFM. Janssen DJA, et al. Among authors: verberkt ca. Breathe (Sheff). 2019 Sep;15(3):e122-e125. doi: 10.1183/20734735.0183-2019. Breathe (Sheff). 2019. PMID: 31777575 Free PMC article.

Cite

Share

7

Cite

Share

Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?

Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Datla S, Dirksen CD, Johnson MJ, van Kuijk SMJ, Wouters EFM, Janssen DJA. Verberkt CA, et al. Eur Respir J. 2018 Jul 19;52(1):1800882. doi: 10.1183/13993003.00882-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 30026306 Free article. No abstract available.

Cite

Share

8

Cite

Share

Multi-disciplinary palliative care is effective in people with symptomatic heart failure: A systematic review and narrative synthesis.

Datla S, Verberkt CA, Hoye A, Janssen DJA, Johnson MJ. Datla S, et al. Among authors: verberkt ca. Palliat Med. 2019 Sep;33(8):1003-1016. doi: 10.1177/0269216319859148. Epub 2019 Jul 15. Palliat Med. 2019. PMID: 31307276

Cite

Share

9

Cite

Share

Reliability of the Fox-walk test in patients with rheumatoid arthritis.

Verberkt CA, Fridén C, Grooten WJ, Opava CH. Verberkt CA, et al. Disabil Rehabil. 2012;34(23):2001-6. doi: 10.3109/09638288.2012.667191. Epub 2012 Mar 29. Disabil Rehabil. 2012. PMID: 22455469

Cite

Share

10

Cite

Share

A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.

Verberkt CA, van den Beuken-van Everdingen MH, Franssen FM, Dirksen CD, Schols JM, Wouters EF, Janssen DJ. Verberkt CA, et al. Contemp Clin Trials. 2016 Mar;47:228-34. doi: 10.1016/j.cct.2016.01.007. Epub 2016 Jan 26. Contemp Clin Trials. 2016. PMID: 26825021 Clinical Trial.

Cite

Share